Hop til indhold

ATMP Denmark celebrates its 1-year anniversary

1 min læsning
Iben B├©gh Nielsen 4513 SH.jpg
Malene 5370 SH.jpg
Iben Bøgh Nielsen, Malene Kristine Nielsen

ATMP Danmark was created to bring together stakeholders across Denmark and support collaboration and coordination on the development, testing, and implementation of ATMP.

Here are five great news items from ATMP Danmark’s first year, showing how the collaboration has already set direction, created momentum, and strengthened efforts across the board.

  • Ambitions have grown, support is clear – and we have now set a clear framework and direction for the work with one unified, coordinating entry point to ATMP.

  • The program secretariat has been continuously expanded with strong competencies that match the increased level of ambition. Today, we are 8 colleagues who, together with our partners, must lift the ambitions

  • We have started establishing a regulatory support function and mapping regulatory challenges, questions, and needs—this is the first step toward shared guidance.

  • We look out into the world and learn from international best practices, which will be translated into pilot projects and recommendations in a Danish context.

  • ATMP Danmark is regarded as a professionally credible collaboration partner, invited to participate in national and international committees and collaborations

Thank you to all of you who are already part of the collaboration.IMG_0166[1].jpeg (1)

ATMP Danmark has been established to strengthen Denmark’s ecosystem for advanced therapies through better coordination, collaboration, and knowledge sharing across research, clinics, authorities, and industry.

At the same time, the ambition is to support Denmark in positioning itself as an attractive and competitive environment for the development, testing, production, and implementation of advanced therapies.